CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
between immune cells in the periphery and deep lymphatic system in MS and healthy controls and in MS, changes in responses to a FDA...
Philadelphia, Pennsylvania, United States
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Philadelphia, Pennsylvania, United States and 73 other locations
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Philadelphia, Pennsylvania, United States and 19 other locations
will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple...
Phase 1
Philadelphia, Pennsylvania, United States and 20 other locations
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Philadelphia, Pennsylvania, United States and 107 other locations
This study will evaluate the pharmacokinetics of ocrelizumab in the breastmilk of lactating women with clinically isolated syndrome (CIS) or multiple...
Phase 4
Philadelphia, Pennsylvania, United States and 9 other locations
This study will evaluate the potential placental transfer of ocrelizumab in women with clinically isolated syndrome (CIS) or multiple sclerosis...
Phase 4
Philadelphia, Pennsylvania, United States and 10 other locations
This study will examine the effectiveness of a neuromyelitis optics spectrum disorder (NMOSD) specific Acceptance and Commitment Therapy (ACT) interv...
Philadelphia, Pennsylvania, United States
This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...
Phase 3
Philadelphia, Pennsylvania, United States and 111 other locations
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...
Phase 3
Philadelphia, Pennsylvania, United States and 122 other locations
Clinical trials
Research sites
Resources
Legal